Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Recursion leverages advanced AI and extensive biological datasets to transform drug discovery processes, aiming to reduce the high failure rates associated with traditional methods. Their innovative platform, Recursion OS, facilitates the rapid identification and development of new therapeutic candidates for various diseases.
Claim this profile to keep your information accurate and add what's missing.
An AI-driven drug discovery and development platform that utilizes vast datasets and machine learning to identify novel therapeutic candidates.
Recursion's mission is to decode biology to radically improve lives by accelerating the development of life-changing treatments through AI and data.
Recursion focuses on aggressive cancers and rare diseases, including various oncology indications and rare genetic disorders.
Recursion uses AI to analyze biological images and vast datasets to identify cellular disruptions and potential drug targets, significantly improving the speed and efficiency of drug development.
Recursion collaborates with leading biopharmaceutical companies such as Roche, Genentech, Bayer, and Merck KGaA to enhance its drug discovery capabilities.
Recursion is headquartered in Salt Lake City, Utah.